Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vir Biotechnology, Inc.

5.45
+0.30005.83%
Post-market: 5.450.00000.00%19:58 EDT
Volume:1.34M
Turnover:7.20M
Market Cap:753.40M
PE:-1.29
High:5.48
Open:5.25
Low:5.18
Close:5.15
Loading ...

Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025

Business Wire
·
13 Feb

Vir Biotechnology Price Target Maintained With a $110.00/Share by HC Wainwright & Co.

Dow Jones
·
31 Jan

Why Vir Biotechnology, Inc. (VIR) Is Skyrocketing Now

Insider Monkey
·
24 Jan

Bank of America Securities Sticks to Their Hold Rating for Vir Biotechnology (VIR)

TIPRANKS
·
15 Jan

Analysts Offer Insights on Healthcare Companies: Vir Biotechnology (VIR), Edgewise Therapeutics (EWTX) and Avadel Pharmaceuticals (AVDL)

TIPRANKS
·
13 Jan

Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA) and Vir Biotechnology (VIR)

TIPRANKS
·
12 Jan

Weekly Winners|FUBO Soars 255%; VIR Surges by 61%; CEG and WBA Jump Over 20%

Tiger Newspress
·
12 Jan

Morgan Stanley Doubles Vir Biotechnology Price Forecast - Here's Why

Benzinga
·
11 Jan

Vir Biotechnology Inc : Morgan Stanley Raises to Overweight From Equal-Weight

THOMSON REUTERS
·
10 Jan

Stock Track | Vir Biotechnology Soars 5.83% as Cancer Drugs Show Promise

Stock Track
·
10 Jan

BUZZ-Morgan Stanley upgrades Vir Biotechnology on cancer drugs trial data

Reuters
·
10 Jan

Vir Biotechnology Price Target Maintained With a $110.00/Share by HC Wainwright & Co.

Dow Jones
·
10 Jan

Biotech Stock Roundup: NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data & More

Zacks
·
10 Jan

VIR Stock Up on Early Safety & Efficacy Data on Two Cancer Candidates

Zacks
·
10 Jan

Vir Biotechnology Reports Promising Trial Results for Cancer Therapies

TipRanks
·
09 Jan

Vir Biotechnology Is Maintained at Neutral by JP Morgan

Dow Jones
·
09 Jan

Morgan Stanley Upgrades Vir Biotechnology to Overweight From Equalweight, Adjusts Price Target to $20 From $10

MT Newswires Live
·
09 Jan

Vir Biotechnology (VIR) Gets a Buy from Barclays

TIPRANKS
·
09 Jan

U.S. RESEARCH ROUNDUP-Accolade, Costco Wholesale, RH

Reuters
·
09 Jan

Vir Biotechnology Inc : JP Morgan Raises Target Price to $14 From $10

THOMSON REUTERS
·
09 Jan